Status:

COMPLETED

Well Being of Obstetric Patients on Minimal Blood Transfusions

Lead Sponsor:

Sanquin Research & Blood Bank Divisions

Collaborating Sponsors:

Erasmus Medical Center

Conditions:

Anemia

Eligibility:

FEMALE

18+ years

Phase:

PHASE4

Brief Summary

Postpartum haemorrhage (PPH) is one of the top five causes of maternal mortality in developed and developing countries. The most important treatment of PPH is red blood cell (RBC) transfusion. The dec...

Detailed Description

The WOMB study is a multicenter trial in patients with PPH, where a restrictive RBC transfusion policy will be compared with a more liberal RBC transfusion policy. Primary outcome in this study is fat...

Eligibility Criteria

Inclusion

  • Women older than 18 years
  • 12-24 hours after delivery (vaginal or caesarean section)
  • Patients are in a clinical obstetric setting
  • Blood loss of more than 1000 mL or Hb decrease ≥ 1,9 g/dL
  • Hb value between 4.8 g/dL and 7.9 g/dL
  • Working knowledge of the national language
  • Written consent for participating this study (informed consent)

Exclusion

  • Patients with severe preeclampsia/ HELLP syndrome
  • RBC transfusion during or after delivery but before t=0
  • Patients with malignancy
  • Patients with severe congenital haemolytic disease, like thalassemia or sickle cell disease
  • Patients with compromised immunological status, congenital or acquired by medical treatment or infectious disease (eg. HIV)
  • Severe active infectious disease at the time of proposed inclusion
  • Severe cardiac, pulmonary, neurological, metabolic or psychiatric co- morbidity (ASA II/III) at the time of proposed inclusion
  • Severe physical complaints (tachycardia of more than 100 bpm, dyspnoea, syncope, heart problems) at the time of intended inclusion
  • Peripartum death of the newborn, or the newborn being in critical condition on neonatal intensive care

Key Trial Info

Start Date :

May 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

Estimated Enrollment :

500 Patients enrolled

Trial Details

Trial ID

NCT00335023

Start Date

May 1 2004

Last Update

July 20 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanquin Blood Bank South West Region

Rotterdam, Netherlands, 3001 KJ